The Effects of Synbiotic Supplementation on Body Mass Index, Metabolic and Inflammatory Biomarkers, and Appetite in Patients with Metabolic Syndrome: A Triple-Blind Randomized Controlled Trial

Autor: Bahram Rashidkhani, Navid Saadat, Samira Rabiei, Rahebeh Shakerhossini, Mehdi Hedayati
Rok vydání: 2018
Předmět:
Blood Glucose
Male
0301 basic medicine
Appetite
Synbiotics
Gut flora
Gastroenterology
Body Mass Index
law.invention
0302 clinical medicine
Randomized controlled trial
law
Insulin
Pharmacology (medical)
media_common
Metabolic Syndrome
Nutrition and Dietetics
biology
digestive
oral
and skin physiology

Fasting
Middle Aged
Lipids
Inflammatory biomarkers
C-Reactive Protein
Treatment Outcome
Research Design
Female
Inflammation Mediators
Adult
medicine.medical_specialty
media_common.quotation_subject
digestive system
03 medical and health sciences
Insulin resistance
Internal medicine
medicine
Humans
Peptide YY
In patient
Aged
030109 nutrition & dietetics
business.industry
030229 sport sciences
medicine.disease
biology.organism_classification
Insulin Resistance
Metabolic syndrome
business
Body mass index
Biomarkers
Food Science
Zdroj: Journal of Dietary Supplements. 16:294-306
ISSN: 1939-022X
1939-0211
Popis: It has been shown recently that metabolic syndrome is associated with gut dysbiosis. The gut microbiota may be the main target for prevention or treatment of metabolic syndrome. We investigated the effects of synbiotic supplementation on metabolic syndrome. In this triple-blinded clinical trial, 46 Iranian patients with metabolic syndrome, from both sexes, aged 25-70 years, who fulfilled inclusion criteria were randomly categorized to receive either the synbiotic or a placebo capsule, twice a day for three months, plus a weight-loss diet using stratified random sampling based on body mass index (BMI). Each synbiotic capsule consisted of seven strains probiotic bacteria (2× 10
Databáze: OpenAIRE